Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Exomide is a South Korea–developed cosmetic exosome-based skin and scalp treatment that delivers stem cell–derived extracellular vesicles (exosomes) along with growth factors, amino acids, peptides, hyaluronic acid, niacinamide, and glutathione to promote skin rejuvenation and hair regeneration.[1][3][7][9][15] Marketed primarily as topical or microneedling-delivered ampoules and solutions, it leverages nano-sized vesicles secreted by mesenchymal or adipose-derived stem cells to enhance cell-to-cell communication, stimulate collagen and elastin production, reduce inflammation and hyperpigmentation, and improve hair follicle activity, density, and scalp health.[1][3][5][7][9][11][19] Exomide is positioned for aesthetic indications such as wrinkles, skin barrier damage, melasma or uneven tone, and various forms of hair thinning and alopecia, and is used as an add-on to procedures like microneedling rather than as a regulated pharmaceutical drug.[3][5][7][9][11][19]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Exomide.